Efficacy and tolerability of sodium-glucose co-transporter-2 inhibitors and glucagon-like peptide-1 receptor agonists: A systematic review and network meta-analysis.
Humaira HusseinFrancesco ZaccardiKamlesh Khunti F MedSciMelanie Jane DaviesEmily PatskoNafeesa N DhalwaniDavid E KloeckerEkaterini IoannidouLaura J GrayPublished in: Diabetes, obesity & metabolism (2020)
Long-acting GLP-1RAs showed superiority in reducing HbA1c levels, body weight and waist circumference. SGLT-2is showed reductions in blood pressure levels. This review provides essential evidence to guide treatment recommendations in the management of type 2 diabetes.